雜志介紹

Expert Review Of Pharmacoeconomics & Outcomes Research雜志介紹

《Expert Review Of Pharmacoeconomics & Outcomes Research》是一本以English為主的未開放獲取國(guó)際優(yōu)秀期刊，中文名稱藥物經(jīng)濟(jì)學(xué)和結(jié)果研究專家評(píng)論，本刊主要出版、報(bào)道醫(yī)學(xué)-HEALTH CARE SCIENCES & SERVICES領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE、SSCI收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為1.8，最新CiteScore 指數(shù)為4。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Cost-effectiveness of anlotinib vs. pembrolizumab and nivolumab as third-line treatment in recurrent small cell lung cancer in China

  Author: Fei, Zhengyang; Rui, Mingjun; Wang, Yingcheng; Ma, Aixia

• Economic evaluation of toripalimab plus chemotherapy compared with chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma in China

  Author: Zheng, Zhiwei; Fang, Ling; Cai, Hongfu; Zhu, Huide

• Cost-effectiveness analysis of atezolizumab plus chemotherapy as first-line treatment for patients with advanced nonsquamous non-small-cell lung cancer in China

  Author: Shang, Fangjian; Zhang, Boyuan; Kang, Shuo

• Comparing measurement properties of EQ-5D and SF-6D in East and South-East Asian populations: a scoping review

  Author: Zhang, Aixue; Mao, Zhuxin; Wang, Zitong; Wu, Jing; Luo, Nan; Wang, Pei

英文介紹

Expert Review Of Pharmacoeconomics & Outcomes Research雜志英文介紹

Expert Review of Pharmacoeconomics & Outcomes Research (ISSN 1473-7167) provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review.

The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections:

Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results

Article Highlights – an executive summary of the author’s most critical points.